FindTrial
Sign In

N/A - ONDANGAPI

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-004372-11-FR
Enrollment
Unknown
Registered
2012-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 15.0 Level: LLT Classification code 10066762 Term: Acute gastroenteritis System Organ Class: 10021881 - Infections and infestations

Interventions

Product Name: ONDANSETRON Pharmaceutical Form: Syrup INN or Proposed INN: ONDANSETRON hydrochloride dihydrate Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration

Sponsors

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

France

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026